MK 467

Known as: MK-467 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2017
051019912017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
OBJECTIVE To characterize the cardiovascular effects of dexmedetomidine, with or without MK-467, following intravenous (IV… (More)
  • figure 1
  • figure 3
Is this relevant?
2016
2016
We investigated the influence of the peripherally acting α2 -adrenoceptor antagonist MK-467 on the sedative and antinociceptive… (More)
Is this relevant?
2014
2014
The haemodynamic interactions of a step infusion with medetomidine (MED) and the peripherally acting alpha-2 antagonist MK-467… (More)
  • figure 1
  • figure 1
  • figure 2
  • figure 2
  • figure 3
Is this relevant?
2013
2013
OBJECTIVE To record, with a thermal camera, peripheral temperature changes during different sedation protocols and to relate the… (More)
Is this relevant?
2013
2013
OBJECTIVE To investigate plasma drug concentrations and the effect of MK-467 (L-659'066) on sedation, heart rate and gut motility… (More)
Is this relevant?
2012
2012
Growing evidence supports the use of (2R-trans)-N-(2-(1,3,4,7,12b-hexahydro-2'-oxo-spiro(2H-benzofuro(2,3-a)quinolizine-2,4… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
2012
2012
Six healthy laboratory Beagles were treated IV with 10 μg/kg dexmedetomidine (DEX) or 10 μg/kg dexmedetomidine combined with 500… (More)
Is this relevant?
2011
2011
Different doses of MK-467, a peripheral alpha(2)-adrenergic receptor antagonist, with or without dexmedetomidine were compared in… (More)
  • figure 3
  • figure 1
  • figure 4
  • figure 2
  • figure 5
Is this relevant?
1994
1994
1. A double-blind, placebo controlled study has been conducted to investigate the consequences of i.v. treatment with MK-467, a… (More)
Is this relevant?
1991
1991
The activity of MK-467, a new peripherally acting alpha 2-antagonist, was assessed in volunteers by a randomized, double-blind… (More)
Is this relevant?